Asthma and COPD Questionnaires Available on SITEpro Tablet - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Asthma and COPD Questionnaires Available on SITEpro Tablet

Source: Applied Clinical Trials

ERT, a global solution provider for patient safety and efficacy endpoint data collection, has received authorization to provide electronic versions of the St. George’s Respiratory Questionnaires (SGRQ) on SITEpro Tablet—ERT’s electronic patient data collection system for use at clinical investigative sites. The authorization applies to the SGRQ, a 50-item questionnaire that measures health status and quality of life in patients with asthma and Chronic Obstructive Pulmonary Disease (COPD), and the SGRQ-C, a shorter version of the questionnaire developed specifically for COPD patients.

In order to receive authorization, ERT conducted a qualification study to verify that the migration of the questionnaires to ERT’s electronic platform remained faithful to its original paper version. ERT scientists successfully completed cognitive interviews among adult patients with asthma and COPD to confirm their understanding of the electronic versions of the questionnaires and that they are appropriate for use in clinical trials.

“We worked closely with ERT’s scientists as they migrated the SGRQ and SGRQ-C to the SITEpro Tablet and demonstrated that they are understood and can be used by patients as was intended with the original paper versions,” said Professor Paul Jones, St. Georges University of London, who developed the instrument. “We are pleased to authorize ERT’s electronic administration of the SGRQ and SGRQ-C to measure health status in patients with airway obstruction diseases during clinical development.”

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here